Claudin-2 Regulates Colorectal Inflammation via Myosin Light Chain Kinase-Dependent Signaling
- 11 January 2013
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 58 (6) , 1546-1559
Abstract
Background Claudins have been demonstrated to be associated with inflammatory bowel disease (IBD), but the specific role of claudin-2 in colorectal inflammation remains undefined. Aims We aimed to determine the role of claudin-2 in TNFα-induced colorectal inflammation. Methods We used claudin-2 (−/−) mice to assess the role of claudin-2 in colon. The mice were intraperitoneally injected with 3 μg of recombinant murine TNFα, and the NF-κB signaling and mRNA expression levels of proinflammatory cytokines and myosin light chain kinase (MLCK) were evaluated. Moreover, in claudin-2 (−/−) mice, colitis was induced by the administration of dextran sodium sulfate (DSS). The involvement of claudin-2 in colorectal inflammation was also investigated using the Caco-2 human colon adenocarcinoma cell line, and the expression of claudin-2 was downregulated using claudin-2 siRNA. Results TNFα-induced colorectal inflammation via NF-κB signaling activation was enhanced in claudin-2 (−/−) mice compared with that in claudin-2 (+/+) mice. MLCK expression level in the colon tissue of claudin-2 (−/−) mice treated with TNFα was enhanced in comparison to that of the claudin-2 (+/+) mice. DSS-induced colitis was more severe in the claudin-2 (−/−) mice than in the claudin-2 (+/−) mice. In in vitro experiments, the decreased expression of claudin-2 enhanced the expressions of IL-6, IL-1β and MLCK. Conclusions Our findings concerning the role of claudin-2 in epithelial inflammatory responses enrich our collective understanding of mucosal homeostasis and intestinal diseases such as IBD. Furthermore, the results of this study indicate that claudin-2 and MLCK are potential therapeutic targets for treatments against intestinal disease.Keywords
This publication has 49 references indexed in Scilit:
- TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signalingJournal of Cell Science, 2010
- Claudin-2–deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubulesProceedings of the National Academy of Sciences, 2010
- Epithelial Myosin Light Chain Kinase Activation Induces Mucosal Interleukin-13 Expression to Alter Tight Junction Ion SelectivityJournal of Biological Chemistry, 2010
- Structure-Function Studies of Claudin Extracellular Domains by Cysteine-scanning MutagenesisJournal of Biological Chemistry, 2009
- Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-κB-inducing Kinase and p38 Mitogen-activated Protein KinaseJournal of Biological Chemistry, 2009
- Targeted Epithelial Tight Junction Dysfunction Causes Immune Activation and Contributes to Development of Experimental ColitisGastroenterology, 2009
- Autocrine Actions of Matrix Metalloproteinase (MMP)-2 Counter the Effects of MMP-9 to Promote Survival and Prevent Terminal Differentiation of Cultured Human KeratinocytesJournal of Investigative Dermatology, 2008
- Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformationLaboratory Investigation, 2008
- Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s diseaseGut, 2006
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993